189 related articles for article (PubMed ID: 16224242)
1. Angiogenesis in malignant lymphoma.
Koster A; Raemaekers JM
Curr Opin Oncol; 2005 Nov; 17(6):611-6. PubMed ID: 16224242
[TBL] [Abstract][Full Text] [Related]
2. [Angiogenesis and hematologic malignancy].
Zini JM; Tobelem G
Bull Cancer; 2007 Jul; 94 Spec No():S241-6. PubMed ID: 17846010
[TBL] [Abstract][Full Text] [Related]
3. The emerging role of angiogenesis inhibitors in hematologic malignancies.
Giles FJ
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):23-9. PubMed ID: 12102577
[TBL] [Abstract][Full Text] [Related]
4. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in hematologic malignancies.
Moehler TM; Neben K; Ho AD; Goldschmidt H
Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.
Ruan J; Hajjar K; Rafii S; Leonard JP
Ann Oncol; 2009 Mar; 20(3):413-24. PubMed ID: 19088170
[TBL] [Abstract][Full Text] [Related]
7. Circulating endothelial cells as a novel marker of angiogenesis.
Mancuso P; Calleri A; Cassi C; Gobbi A; Capillo M; Pruneri G; Martinelli G; Bertolini F
Adv Exp Med Biol; 2003; 522():83-97. PubMed ID: 12674213
[TBL] [Abstract][Full Text] [Related]
8. Role of tumour angiogenesis in haematological malignancies.
Medinger M; Passweg J
Swiss Med Wkly; 2014; 144():w14050. PubMed ID: 25375891
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches.
Poon RT; Fan ST; Wong J
Ann Surg; 2003 Jul; 238(1):9-28. PubMed ID: 12832961
[TBL] [Abstract][Full Text] [Related]
10. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
Gratzinger D; Zhao S; Marinelli RJ; Kapp AV; Tibshirani RJ; Hammer AS; Hamilton-Dutoit S; Natkunam Y
Am J Pathol; 2007 Apr; 170(4):1362-9. PubMed ID: 17392174
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma.
Pang R; Poon RT
Cancer Lett; 2006 Oct; 242(2):151-67. PubMed ID: 16564617
[TBL] [Abstract][Full Text] [Related]
12. Accelerated lymphangiogenesis in malignant lymphoma: possible role of VEGF-A and VEGF-C.
Kadowaki I; Ichinohasama R; Harigae H; Ishizawa K; Okitsu Y; Kameoka J; Sasaki T
Br J Haematol; 2005 Sep; 130(6):869-77. PubMed ID: 16156857
[TBL] [Abstract][Full Text] [Related]
13. Microvessel density in normal lymph nodes and lymphomas of dogs and their correlation with vascular endothelial growth factor expression.
Wolfesberger B; Tonar Z; Witter K; Guija de Arespacohaga A; Skalicky M; Walter I; Thalhammer JG; Egger GF
Res Vet Sci; 2008 Aug; 85(1):56-61. PubMed ID: 17888471
[TBL] [Abstract][Full Text] [Related]
14. [Tumoral angiogenesis: physiopathology, prognostic value and therapeutic perspectives].
André T; Chastre E; Kotelevets L; Vaillant JC; Louvet C; Balosso J; Le Gall E; Prévot S; Gespach C
Rev Med Interne; 1998 Dec; 19(12):904-13. PubMed ID: 9887458
[TBL] [Abstract][Full Text] [Related]
15. Expression of vascular endothelial growth factor (VEGF) and VEGF receptors in tumor angiogenesis and malignancies.
Pradeep CR; Sunila ES; Kuttan G
Integr Cancer Ther; 2005 Dec; 4(4):315-21. PubMed ID: 16282508
[TBL] [Abstract][Full Text] [Related]
16. Role of VEGF/VEGFR in the pathogenesis of leukemias and as treatment targets (Review).
Song G; Li Y; Jiang G
Oncol Rep; 2012 Dec; 28(6):1935-44. PubMed ID: 22993103
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in lymphoproliferative disorders: a therapeutic target?
Aboudola S; Kini AR
Curr Opin Hematol; 2005 Jul; 12(4):279-83. PubMed ID: 15928484
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor.
Jain RK
Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032
[TBL] [Abstract][Full Text] [Related]
19. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
20. The vascular endothelial growth factor (VEGF) signaling pathway: a therapeutic target in patients with hematologic malignancies.
Giles FJ
Oncologist; 2001; 6 Suppl 5():32-9. PubMed ID: 11700390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
